Showing results (121-130 of 499) with videos related to
Sort By:
Pageof 50
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell linesYangbing Zhao, Zhili Zheng, Paul F Robbins, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokineCary Hsu, Marybeth S Hughes, Zhili Zheng, et al.Cancer Research|March 9, 2005
Bcl-2 overexpression enhances tumor-specific T-cell survivalJehad Charo, Steven E Finkelstein, Navrose Grewal, et al.European Journal of Immunology|October 12, 2013
2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR systemBaoyu Liu, Shi Zhong, Karolina Malecek, et al.Health Services Research|May 25, 2013
An empirical comparison of tree-based methods for propensity score estimationStephanie Watkins, Michele Jonsson-Funk, M Alan Brookhart, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockadeWillemijn B Breunis, Eduardo Tarazona-Santos, Renee Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomeraseMaria R Parkhurst, John P Riley, Takehito Igarashi, et al.Cancer|January 30, 2014
Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiationJennifer Tseng, Deborah E Citrin, Meryl Waldman, et al.Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
A pilot study of antiangiogenic therapy with bevacizumab and thalidomide in patients with metastatic renal cell carcinomaDina M Elaraj, Donald E White, Seth M Steinberg, et al.Pageof 50